Header cover image

Belgian (BEL20) Biotech Industry Analysis

UpdatedFeb 23, 2025
DataAggregated Company Financials
Companies3
  • 7D1.9%
  • 3M5.4%
  • 1Y63.9%
  • YTD1.4%

In the last week, the Biotech industry is up 1.9%, with argenx up 1.9%. This means that the industry has gained 64% over the past year. Looking forward, earnings are forecast to grow by 42% annually.

Industry Valuation and Performance

Has the Belgian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 23 Feb 2025€37.7b€1.9b-€47,340,078.70n/a-795.8x20.2x
Tue, 21 Jan 2025€38.3b€1.9b-€47,569,748.80n/a-806.1x20.4x
Thu, 19 Dec 2024€36.9b€1.9b-€47,315,902.90n/a-779.5x19.8x
Sat, 16 Nov 2024€32.3b€1.9b-€47,098,320.70n/a-686.5x17.4x
Mon, 14 Oct 2024€29.1b€1.6b-€195,697,502.50n/a-148.7x18.6x
Wed, 11 Sep 2024€29.2b€1.5b-€194,497,915.00n/a-150.3x18.9x
Fri, 09 Aug 2024€28.0b€1.6b-€196,377,889.00n/a-142.6x17.9x
Sun, 07 Jul 2024€24.0b€1.4b-€311,533,127.50n/a-77x17.4x
Tue, 04 Jun 2024€20.7b€1.4b-€310,063,232.50n/a-66.8x15.1x
Thu, 02 May 2024€20.9b€1.2b-€285,879,176.90n/a-73.1x17x
Sat, 30 Mar 2024€21.8b€1.2b-€305,011,131.00n/a-71.4x17.9x
Mon, 26 Feb 2024€22.4b€990.2m-€248,195,677.70n/a-90.3x22.6x
Wed, 24 Jan 2024€20.0b€1.0b-€288,715,145.00n/a-69.3x19.1x
Fri, 22 Dec 2023€17.8b€1.0b-€285,877,732.00n/a-62.2x17.2x
Sun, 19 Nov 2023€26.9b€1.0b-€287,572,992.00n/a-93.4x25.8x
Tue, 17 Oct 2023€27.6b€884.3m-€453,609,090.00n/a-60.9x31.3x
Thu, 14 Sep 2023€28.3b€867.1m-€451,008,270.00n/a-62.7x32.6x
Sat, 12 Aug 2023€26.8b€841.2m-€452,143,064.00n/a-59.2x31.8x
Mon, 10 Jul 2023€19.5b€661.8m-€556,103,944.00n/a-35.1x29.5x
Wed, 07 Jun 2023€21.1b€677.5m-€568,899,594.00n/a-37.2x31.2x
Fri, 05 May 2023€19.9b€453.3m-€725,552,760.00n/a-27.5x44x
Sun, 02 Apr 2023€19.1b€459.7m-€735,726,873.00n/a-25.9x41.5x
Tue, 28 Feb 2023€19.4b€317.1m-€921,001,047.00n/a-21.1x61.2x
Thu, 26 Jan 2023€19.5b€308.8m-€896,055,919.00n/a-21.8x63.3x
Sat, 24 Dec 2022€19.9b€316.3m-€914,027,333.00n/a-21.8x62.9x
Mon, 21 Nov 2022€20.0b€323.8m-€936,296,175.00n/a-21.4x61.9x
Wed, 19 Oct 2022€21.2b€192.9m-€983,749,032.00n/a-21.5x109.9x
Fri, 16 Sep 2022€21.1b€170.9m-€967,359,588.00n/a-21.9x123.7x
Sun, 14 Aug 2022€20.3b€165.4m-€940,991,112.00n/a-21.6x122.9x
Tue, 12 Jul 2022€19.8b€401.1m-€646,357,914.00n/a-30.7x49.4x
Thu, 09 Jun 2022€16.6b€378.2m-€610,794,980.00n/a-27.1x43.8x
Sat, 07 May 2022€16.2b€381.8m-€617,495,341.00n/a-26.3x42.5x
Mon, 04 Apr 2022€15.2b€498.8m-€422,675,902.00n/a-36x30.5x
Wed, 02 Mar 2022€13.8b€476.3m-€378,061,519.00n/a-36.5x29x
Price to Earnings Ratio

-36.5x


Total Market Cap: €13.8bTotal Earnings: -€378,061,519.00Total Revenue: €476.3mTotal Market Cap vs Earnings and Revenue0%0%0%
Belgian Biotech Industry Price to Earnings3Y Average -130.4x202320242025
Current Industry PE
    There are only 3 companies in the Belgian Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 58% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Belgian Healthcare industry?

BE Market0.37%
Healthcare0.92%
Biotech1.90%
Biotech1.90%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ARGX argenx€619.201.9%
+€692.7m
64.0%PS20.6x
CYAD Celyad Oncology€0.5739.1%
+€6.6m
58.6%PS328.6x
ALEMS European Medical Solutions€6.586.1%
+€1.6m
-15.0%PS0.6x
BIOS BioSenic€0.00442.3%
+€315.7k
-83.9%PS0.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CYAD

€0.57

Celyad Oncology

7D

39.1%

1Y

58.6%

ARGX

€619.20

argenx

7D

1.9%

1Y

64.0%

BIOS

€0.0044

BioSenic

7D

2.3%

1Y

-83.9%

OXUR

€0.20

Oxurion

7D

-4.8%

1Y

-93.3%